![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 35, 31774-31780, August 30, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Endocrine Unit, Massachusetts General Hospital and
Department of Medicine, Harvard Medical School,
Boston, Massachusetts 02114
The human parathyroid
hormone (PTH) receptor (hPTH1R), containing a 9-amino acid sequence of
rhodopsin at its C terminus, was transiently expressed in COS-7 cells
and solubilized with 0.25% n-dodecyl maltoside.
Approximately 18 µg of hPTH1R were purified to homogeneity per mg of
crude membranes by single-step affinity chromatography using 1D4, a
monoclonal antibody to a rhodopsin epitope. The N terminus of the
hPTH1R is Tyr23, consistent with removal of the 22-amino
acid signal peptide. Comparisons of hPTH1R by quantitative
immunoblotting and Scatchard analysis revealed that 75% of the
receptors in membrane preparations were functional; there was little,
if any, loss of functional receptors during purification. The binding
affinity of the purified hPTH1R was slightly lower than
membrane-embedded hPTH1R (Kd = 16.5 ± 1.3 versus 11.9 ± 1.9 nM), and the purified
receptors bound rat
[Nle8,21,Tyr34]PTH-(1-34)-NH2
(PTH-(1-34)), and rat
[Ile5,Trp23,Tyr36]PTHrP-(5-36)-NH2
with indistinguishable affinity. Maximal displacement of
125I-PTH-(1-34) binding by rat
[
aminoisobutyric acid
(Aib)1,3,Nle8,Gln10,Har11,Ala12,Trp14,Arg19,Tyr21]PTH-(1-21)-NH2
and rat
[Aib1,3,Gln10,Har11,Ala12,Trp14]PTH-(1-14)-NH2
of 80 and 10%, respectively, indicates that both N-terminal and
juxtamembrane ligand binding determinants are functional in the
purified hPTH1R. Finally, PTH stimulated [35S]GTP
S
incorporation into G
s in a time- and
dose-dependent manner, when recombinant hPTH1R,
G
s-, and 
-subunits were reconstituted in
phospholipid vesicles. The methods described will enable structural studies of the hPTH1R, and they provide an efficient and general technique to purify proteins, particularly those of the class II G
protein-coupled receptor family.
To whom correspondence should be addressed: Endocrine Unit,
Wellman 501, Massachusetts General Hospital, Boston, MA 02114. Tel.:
617-726-3966; Fax: 617-726-7543; E-mail:
segre@helix.mgh.harvard.edu.
This article has been cited by other articles:
![]() |
T. Dean, A. Linglart, M. J. Mahon, M. Bastepe, H. Juppner, J. T. Potts Jr., and T. J. Gardella Mechanisms of Ligand Binding to the Parathyroid Hormone (PTH)/PTH-Related Protein Receptor: Selectivity of a Modified PTH(1-15) Radioligand for G{alpha}S-Coupled Receptor Conformations Mol. Endocrinol., April 1, 2006; 20(4): 931 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shimada, M. J. Mahon, P. A. Greer, and G. V. Segre The Receptor for Parathyroid Hormone and Parathyroid Hormone-Related Peptide Is Hydrolyzed and Its Signaling Properties Are Altered by Directly Binding the Calpain Small Subunit Endocrinology, May 1, 2005; 146(5): 2336 - 2344. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |